166 related articles for article (PubMed ID: 19480853)
1. Secretion of vascular endothelial growth factor by oral squamous cell carcinoma cells skews endothelial cells to suppress T-cell functions.
Mulligan JK; Day TA; Gillespie MB; Rosenzweig SA; Young MR
Hum Immunol; 2009 Jun; 70(6):375-82. PubMed ID: 19480853
[TBL] [Abstract][Full Text] [Related]
2. Tumors skew endothelial cells to disrupt NK cell, T-cell and macrophage functions.
Mulligan JK; Lathers DM; Young MR
Cancer Immunol Immunother; 2008 Jul; 57(7):951-61. PubMed ID: 18058097
[TBL] [Abstract][Full Text] [Related]
3. Tumor secretion of VEGF induces endothelial cells to suppress T cell functions through the production of PGE2.
Mulligan JK; Rosenzweig SA; Young MR
J Immunother; 2010; 33(2):126-35. PubMed ID: 20145550
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
[TBL] [Abstract][Full Text] [Related]
5. Vascular Endothelial Growth Factor A (VEGF-A) and Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) as Potential Biomarkers for Oral Squamous Cell Carcinoma: A Sri Lankan Study.
Edirisinghe ST; Weerasekera M; De Silva DK; Devmini MT; Pathmaperuma S; Wijesinghe GK; Nisansala T; Maddumage A; Huzaini H; Rich AM; De Silva H; Trudy M; Goonasinghe R; De Silva K; Yasawardena S
Asian Pac J Cancer Prev; 2023 Jan; 24(1):267-274. PubMed ID: 36708576
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of AT-rich interaction domain 2 underlies natural killer cell dysfunction in oral squamous cell carcinoma.
Li W; An N; Wang M; Liu X; Mei Z
Immunol Cell Biol; 2023 Jan; 101(1):78-90. PubMed ID: 36269235
[TBL] [Abstract][Full Text] [Related]
7. The secretion of IL-6 by CpG-ODN-treated cancer cells promotes T-cell immune responses partly through the TLR-9/AP-1 pathway in oral squamous cell carcinoma.
Ruan M; Thorn K; Liu S; Li S; Yang W; Zhang C; Zhang C
Int J Oncol; 2014 Jun; 44(6):2103-10. PubMed ID: 24676671
[TBL] [Abstract][Full Text] [Related]
8. 14-3-3ζ regulates immune response through Stat3 signaling in oral squamous cell carcinoma.
Han X; Han Y; Jiao H; Jie Y
Mol Cells; 2015; 38(2):112-21. PubMed ID: 25556369
[TBL] [Abstract][Full Text] [Related]
9. Expansion of PMN-myeloid derived suppressor cells and their clinical relevance in patients with oral squamous cell carcinoma.
Zhong LM; Liu ZG; Zhou X; Song SH; Weng GY; Wen Y; Liu FB; Cao DL; Liu YF
Oral Oncol; 2019 Aug; 95():157-163. PubMed ID: 31345384
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide-squamous cell carcinoma-monocyte interactions induce cancer-supporting factors leading to rapid STAT3 activation.
Kurago ZB; Lam-ubol A; Stetsenko A; De La Mater C; Chen Y; Dawson DV
Head Neck Pathol; 2008 Mar; 2(1):1-12. PubMed ID: 19603082
[TBL] [Abstract][Full Text] [Related]
11. Granzyme B-truncated VEGF fusion protein represses angiogenesis and tumor growth of OSCC.
Lv XZ; Zheng MY; Lin ZQ; Zhao M; Wang H; Zeng WS
Oral Dis; 2016 Oct; 22(7):688-96. PubMed ID: 27291760
[TBL] [Abstract][Full Text] [Related]
12. Expression of vascular endothelial growth factor A, B, C, and D in oral squamous cell carcinoma.
Shintani S; Li C; Ishikawa T; Mihara M; Nakashiro K; Hamakawa H
Oral Oncol; 2004 Jan; 40(1):13-20. PubMed ID: 14662410
[TBL] [Abstract][Full Text] [Related]
13. [The expression of Maspin and VEGF gene in oral squamous cell carcinoma and its significance].
Zhang L; Tang ZG; Zhou ZG; Tong XJ; Li XL
Shanghai Kou Qiang Yi Xue; 2005 Dec; 14(6):557-60. PubMed ID: 16400477
[TBL] [Abstract][Full Text] [Related]
14. Tumour cell-derived WNT5B modulates in vitro lymphangiogenesis via induction of partial endothelial-mesenchymal transition of lymphatic endothelial cells.
Wang SH; Chang JS; Hsiao JR; Yen YC; Jiang SS; Liu SH; Chen YL; Shen YY; Chang JY; Chen YW
Oncogene; 2017 Mar; 36(11):1503-1515. PubMed ID: 27593938
[TBL] [Abstract][Full Text] [Related]
15. Ganoderma lucidum polysaccharides antagonize the suppression on lymphocytes induced by culture supernatants of B16F10 melanoma cells.
Sun LX; Lin ZB; Duan XS; Lu J; Ge ZH; Li XJ; Li M; Xing EH; Jia J; Lan TF; Li WD
J Pharm Pharmacol; 2011 May; 63(5):725-35. PubMed ID: 21492175
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-induced up-regulation of angiogenin, besides VEGF, is related to progression of oral cancer.
Kishimoto K; Yoshida S; Ibaragi S; Yoshioka N; Okui T; Hu GF; Sasaki A
Oral Oncol; 2012 Nov; 48(11):1120-7. PubMed ID: 22694909
[TBL] [Abstract][Full Text] [Related]
17. RNAi-mediated downregulation of oral cancer overexpressed 1 (ORAOV1) inhibits vascular endothelial cell proliferation, migration, invasion, and tube formation.
Zhao X; Liu D; Wang L; Wu R; Zeng X; Dan H; Ji N; Jiang L; Zhou Y; Chen Q
J Oral Pathol Med; 2016 Apr; 45(4):256-61. PubMed ID: 26449957
[TBL] [Abstract][Full Text] [Related]
18. The expression of receptor for advanced glycation end products is associated with angiogenesis in human oral squamous cell carcinoma.
Sasahira T; Kirita T; Bhawal UK; Ikeda M; Nagasawa A; Yamamoto K; Kuniyasu H
Virchows Arch; 2007 Mar; 450(3):287-95. PubMed ID: 17235565
[TBL] [Abstract][Full Text] [Related]
19. Prediction of outcome of patients with oral squamous cell carcinoma using vascular invasion and the strongly positive expression of vascular endothelial growth factors.
Seki S; Fujiwara M; Matsuura M; Fujita S; Ikeda H; Asahina I; Ikeda T
Oral Oncol; 2011 Jul; 47(7):588-93. PubMed ID: 21602095
[TBL] [Abstract][Full Text] [Related]
20. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression.
Shang ZJ; Li JR
J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
